Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,995
+$17,841 QoQ
Shares Held
2,363
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#306
of 626 holders
Holding Since
Sep 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Siemens Fonds Invest GmbH holds $98,160,775 across 10 Drug Manufacturers - General names. OGN ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,769 | $24,910,963 | |
| 2 | JNJ |
Johnson & Johnson
|
81,643 | $20,734,872 | |
| 3 | ABBV |
AbbVie Inc.
|
57,804 | $14,545,798 | |
| 4 | AMGN |
Amgen Inc
|
28,142 | $10,190,781 | |
| 5 | MRK |
Merck & Co., Inc.
|
75,099 | $9,650,221 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
59,147 | $7,472,631 | |
| 7 | PFE |
Pfizer Inc
|
226,573 | $5,455,877 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
76,062 | $4,382,692 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,995 | 2,363 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,154 | 2,363 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,942 | 2,363 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,236 | 2,363 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,873 | 2,363 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $35,185 | 2,363 | Shares | Sole | 2025-05-15 | |
| 2021-09-30 | $278,157 | 8,483 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||